Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study-Reference-Cited by-同舟云学术

Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study

Published:2020-06 Issue: Volume:76 Page:20-24
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Mahta Ali,Yaghi Shadi,Reznik Michael E.,Thompson Bradford B.,Wendell Linda C.,Rao Shyam,Potter Nicholas S.,Dakay Katarina B.,Cutting Shawna,Mac Grory Brian,Burton Tina,Saad Ali,Sacchetti Daniel C.,Stretz Christoph,El Jamal Sleiman,Mahmoud Leana N.,Moody Scott,Murray Kayleigh,Costa Samantha,Sellke Frank W.,Kamel Hooman,Furie Karen L.

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference22 articles.

1. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult;Sandhaus;Chronic Obstr Pulm Dis.,2016

2. Alpha-1 antitrypsin deficiency: From the lung to the heart?;Curjuric;Atherosclerosis.,2018

3. Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection;Schievink;Lancet,1994

4. Emphysema: A potential risk factor for subarachnoid hemorrhage and ruptured aortic aneurysm;Mahta;Stroke,2019

5. Common coding variant in serpina1 increases the risk for large artery stroke;Malik;Proc Natl Acad Sci U S A.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Molecular Docking and ADMET Studies of Alpha-1-antitrypsin with Nanoparticles;2024-05-27

2. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies;Pharmaceuticals;2022-10-18

3. Novel insights into the relationship between α-1 anti-trypsin with the pathological development of cardio-metabolic disorders;International Immunopharmacology;2022-10

4. Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation;Journal of Cardiovascular Medicine;2022-10

5. Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases;Clinica Chimica Acta;2022-09